Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1034 | 1060 | 1046 | 1114 | 1320 | 1678 |
Fund Return | 3.41% | 6.05% | 4.57% | 3.68% | 5.71% | 5.31% |
Place in category | 87 | 133 | 221 | 306 | 277 | 201 |
% in Category | 14 | 19 | 38 | 56 | 62 | 73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SIHong Kong Equity C CHF Acc | 9.76B | 3.44 | -16.55 | 2.37 | ||
SIAsian Equity Yield C CHF Acc | 1.01B | 10.58 | -2.77 | 5.01 | ||
SISwiss Small Mid Cap Equity C Acc | 138.83M | 1.33 | -2.29 | 6.20 | ||
SISwiss Small Mid Cap Equity I Acc | 138.83M | 1.55 | -1.02 | 7.55 | ||
SISwiss Equity Opportunities C Acc | 32.46M | 3.24 | 2.66 | 4.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.51B | 3.85 | 3.74 | 6.24 | ||
Raiffeisen Futura Swiss Stock A | 2.19B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHF | 1.79B | 2.43 | 3.56 | 5.81 | ||
UBS CH Equity Fund Swiss Income CHQ | 1.79B | 2.59 | 4.20 | 6.41 | ||
UBAM Swiss Equity AD CHF Inc | 1.83B | 7.99 | -0.55 | 5.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 9.15 | 93.37 | +0.81% | |
Nestle | CH0038863350 | 8.97 | 96.62 | +1.26% | |
Roche Holding Participation | CH0012032048 | 8.80 | 237.10 | +0.98% | |
Richemont | CH0210483332 | 5.90 | 144.75 | +5.31% | |
Zurich Insurance Group | CH0011075394 | 5.08 | 471.00 | +0.41% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review